The Department of Urology participates in a variety of medical studies. An interdisciplinary team of physicians, PhD's, medical students, nurses, and other highly-qualified professionals collaborate on the following projects. In fact, we are an active member of the Southwest Oncology Group, and participate in a variety of local, national, and international research trials. Our department has been fortunate to work with the following organizations: - Alza Corporation
- Astra Zeneca
- Barr Laboratories
- Department of Defense
- Eli Lilly
- GlaxoSmithKline
- Merck
- Novartis
- Pfizer
- Sanofi - Synthelabo
- Schering Plough
- TAP
Examples of projects include various drug therapies and quality-of-life assessments. Current research involves the following diagnoses: - bladder cancer
- benign prostatic hyperplasia
- prostate cancer
- overactive bladder
- erectile dysfunction
- acute urinary retention
If you would like more information on any of our clinical trials, please call our research coordinator at (843) 876-0630. We are committed to discovering, understanding, and healing.
| 
